125 related articles for article (PubMed ID: 37810983)
1. MRI and amino acid PET detection of whole-brain tumor burden.
Chen P; Scarpelli ML; Healey DR; Mehta S; Quarles CC
Front Oncol; 2023; 13():1248249. PubMed ID: 37810983
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Imaging Glioblastoma With
Scarpelli ML; Healey DR; Mehta S; Quarles CC
Front Oncol; 2022; 12():829050. PubMed ID: 35174096
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing Progression from Pseudoprogression in Glioblastoma Using
Nabavizadeh A; Bagley SJ; Doot RK; Ware JB; Young AJ; Ghodasara S; Zhao C; Anderson H; Schubert E; Carpenter EL; Till J; Henderson F; Pantel AR; Chen HI; Lee JYK; Amankulor NM; O'Rourke DM; Desai A; Nasrallah MP; Brem S
J Nucl Med; 2023 Jun; 64(6):852-858. PubMed ID: 36549916
[TBL] [Abstract][Full Text] [Related]
5. Exploratory Analysis of Serial
Fatania K; Frood R; Tyyger M; McDermott G; Fernandez S; Shaw GC; Boissinot M; Salvatore D; Ottobrini L; Teh I; Wright J; Bailey MA; Koch-Paszkowski J; Schneider JE; Buckley DL; Murray L; Scarsbrook A; Short SC; Currie S
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884545
[TBL] [Abstract][Full Text] [Related]
6. Combined
Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Giskeødegård GF; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
J Nucl Med; 2018 May; 59(5):762-768. PubMed ID: 28986510
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma PET/MRI: kinetic investigation of [
Lindemann M; Oteiza A; Martin-Armas M; Guttormsen Y; Moldes-Anaya A; Berzaghi R; Bogsrud TV; Bach-Gansmo T; Sundset R; Kranz M
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1183-1194. PubMed ID: 36416908
[TBL] [Abstract][Full Text] [Related]
8.
Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
[TBL] [Abstract][Full Text] [Related]
9. A PET/MRI study towards finding the optimal [
Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158
[TBL] [Abstract][Full Text] [Related]
10. Impact of
Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R; Cooper S; Chen Z; Schuster DM
J Nucl Med; 2017 Mar; 58(3):412-418. PubMed ID: 27609792
[TBL] [Abstract][Full Text] [Related]
11. [
Zanoni L; Bianchi L; Nanni C; Pultrone C; Giunchi F; Bossert I; Matti A; Schiavina R; Fiorentino M; Romagnoli D; Fonti C; Lodi F; D'Errico A; Brunocilla E; Porreca A; Fanti S
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):390-409. PubMed ID: 34213609
[TBL] [Abstract][Full Text] [Related]
12. Determining the extent of tumor resection at surgical planning with
Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M
Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623
[TBL] [Abstract][Full Text] [Related]
13. Phase IIa clinical study of [
Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
[TBL] [Abstract][Full Text] [Related]
14. Utility of
Galgano SJ; McDonald AM; Rais-Bahrami S; Porter KK; Choudhary G; Burgan C; Bhambhvani P; Nix JW; Morgan DE; Li Y; Thomas JV; McConathy J
AJR Am J Roentgenol; 2021 Sep; 217(3):720-729. PubMed ID: 33052718
[No Abstract] [Full Text] [Related]
15. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of fluciclovine (
Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V; Jani AB; Kitajima H; Osunkoya AO; Ormenisan-Gherasim C; Goodman MM; Schuster DM
Eur J Radiol; 2018 May; 102():1-8. PubMed ID: 29685521
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions.
Rakheja R; DeMello L; Chandarana H; Glielmi C; Geppert C; Faul D; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1120-3. PubMed ID: 24147486
[TBL] [Abstract][Full Text] [Related]
18. Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.
Bagci U; Kramer-Marek G; Mollura DJ
EJNMMI Res; 2013 Jul; 3(1):49. PubMed ID: 23829944
[TBL] [Abstract][Full Text] [Related]
19. Multimodal
Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
